Most Canadians believe that their health is shaped by luck, genetics, lifestyle choices, and treatment options--and government agencies, public health units, and disease associations all reinforce this perception. This study, however, tells a different story, arguing that it is the social determinants of health, as imposed by the financial markets, that dictate the health of Canadians today. Showing that health care can be greatly improved with simple changes to social policy, the discussion describes the impact of food, housing, employment, education, and social services on the nation`s health.
Sommes-nous en train d'assister à la fin du modèle de santé français ? Notre système fondé sur l'égal accès de tous à des soins de qualité et sur la solidarité...
Gridlock: The Unhealthy Politics of Health Care in Vermont
The Swine Flu Affair: Decision-making on a Slippery Disease
Discusses reasons why women's health needs must be addressed. It includes a background discussion on the health care system, change in the Canadian health community, and the women's community.
Botting, B. (1997) 'Mortality in Childhood', in Drever, F. and Whitehead, M. (eds), Health Inequalities, op. cit. ... Bunker, J. B., Frazier, H. S. and Mosteller, F. (1994) 'Improving Health: Measuring Effects of Medical Care', ...
Patients, Power and Politics examines what health care and services would look like if they were based on the experiences and concerns of their users.
Wu C , Hannan EL , Ryan TJ , Bennett E , Culliford AT , Gold JP , Isom OW , Jones RH , McNeil B , Rose EA , Subramanian VA . ... Hannan EL , Racz M , Ryan TJ , McCallister BD , Johnson LW , Arani DT , Guerci AD , Sosa J , Topol EJ .
What, then, are the predictors of adult-onset diabetes, heart attacks or stroke, and many other diseases? This volume summarises how socio-economic factors affect the health of Canadians.
Lopez , A. D. , Mathers , C. D. , Ezzati , M. , Jamison , D. T. , & Murray , C. J. L. ( Eds . ) . 2006. Global burden of disease and risk factors . Washington : The World Bank . Macran , S. , & Kind , P. 2001 .
According to the CSDD , the average FDA review time for approved new chemical entities decreased from 35.6 months in 1984–1986 to 16.8 months in 1996–1998 ( Kaitin and Healy , 2000 ) . Thus , in a little more than a decade , the FDA ...